Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

E1Z11 A Cohort Study to Evaluate Genetic Predictors of Aromatase Inhibitor, AIMSS

NCT02874222 is registered in ClinicalTrials.gov with United States Naval Medical Center, San Diego as lead sponsor.

NCT NCT02874222
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02874222 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
E1Z11 A Cohort Study to Evaluate Genetic Predictors of Aromatase Inhibitor, AIMSS
Lead sponsor
United States Naval Medical Center, San Diego
Phase
Observational
Overall status
Completed
Start date
May 31, 2015
Completion date
May 1, 2024
Enrollment
13 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer